Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic sclerosis (scleroderma): clinical, genetic, and serologic subsets.

J Z Livingston, T E Scott, F M Wigley

    The Journal of Rheumatology
    |June 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Decreased recognition of paraneoplastic pemphigus in patients previously treated with anti-CD 20 monoclonal antibodies.

    The British journal of dermatology·2019
    Same author

    Pain severity as a mediator of the association between depressive symptoms and physical performance in knee osteoarthritis.

    Osteoarthritis and cartilage·2018
    Same author

    Factors associated with the orthopaedic surgeon's decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1905 patients.

    Osteoarthritis and cartilage·2018
    Same author

    Older men who sustain a hip fracture experience greater declines in bone mineral density at the contralateral hip than non-fractured comparators.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
    Same author

    A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study.

    Osteoarthritis and cartilage·2017
    Same author

    Clinical algorithms to aid osteoarthritis guideline dissemination.

    Osteoarthritis and cartilage·2016
    Same journal

    Clinical Features and Outcome Measures Across Still Disease (Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still Disease) Cohorts Worldwide: A Systematic Literature Review.

    The Journal of rheumatology·2026
    Same journal

    Concurrent Calcium Pyrophosphate Deposition Disease and Gout of the Cervical Spine Presenting With Subacute Neck Pain and Radiculopathy.

    The Journal of rheumatology·2026
    Same journal

    The Need for Weight Communication Guidelines in Pediatric Rheumatology.

    The Journal of rheumatology·2026
    Same journal

    Bimekizumab Improves Health Status and Work Productivity, With Reduced Productivity Costs, to 3 Years in Axial Spondyloarthritis and Psoriatic Arthritis.

    The Journal of rheumatology·2026
    Same journal

    Qualitative Analysis of Physical Activity Engagement in Women with Self-Reported SLE: The Role of Symptoms, Healthcare Providers, and the Environment.

    The Journal of rheumatology·2026
    Same journal

    Tumoral Calcinosis-like Calcification of the Proximal Interphalangeal Joint Mimicking Rheumatoid Arthritis Flare.

    The Journal of rheumatology·2026
    See all related articles

    Genetic and autoantibody markers help define systemic sclerosis subtypes. Specific human leukocyte antigen (HLA) types and autoantibodies like anticentromere and anti-Scl-70 correlate with disease presentation and patient race.

    Area of Science:

    • Immunogenetics
    • Rheumatology
    • Clinical Medicine

    Background:

    • Systemic sclerosis (SSc) is a complex autoimmune disease with diverse clinical manifestations.
    • Understanding the genetic and serological underpinnings of SSc is crucial for defining its subtypes.

    Purpose of the Study:

    • To investigate the association between immunogenetic markers, autoantibodies, and clinical features in patients with systemic sclerosis.
    • To explore potential differences in these markers across racial groups and disease subsets.

    Main Methods:

    • Study included 47 patients with systemic sclerosis (35 Caucasian, 12 black).
    • Analyzed human leukocyte antigen (HLA) types, autoantibodies (anticentromere, anti-Scl-70), and complement allotypes.
    • Correlated findings with clinical presentation (generalized vs. limited skin involvement).

    Related Experiment Videos

    Main Results:

    • Increased frequencies of HLA-DR1, HLA-DR5, and HLA-DRw52 in Caucasian patients.
    • Elevated HLA-DR6.1 in black patients.
    • Anticentromere antibody associated with limited SSc in Caucasian patients; anti-Scl-70 antibody linked to generalized SSc and HLA-DR2.
    • No significant increase in complement allotypes observed.

    Conclusions:

    • Genetic and serological markers can help delineate distinct clinical subsets of systemic sclerosis.
    • Specific HLA types and autoantibodies show associations with disease subtypes and race.
    • Further research into these markers may aid in personalized medicine approaches for SSc.